China Pharma prices $5 million direct offering at $2 per share

China Pharma Holdings, Inc. (NYSE American: CPHI) announced the pricing of a registered direct offering of 2.5 million shares of common stock at $2 per share, according to a press release.

The offering is expected to generate $5 million in gross proceeds before placement agent fees and other expenses. The company said it plans to use the net proceeds for working capital and general corporate purposes.

The offering was expected to close on or about July 23, 2026. FT Global Capital, Inc. is acting as the exclusive placement agent.

The offering was made under the company's shelf registration statement on Form F-3, filed with the U.S. Securities and Exchange Commission on January 12, 2024, and declared effective on February 14, 2024.

You May Also Be Interested In

• DeFi Development Corp. plans $20M preferred stock offering
• Global Water Resources raises $20M through stock sale and credit line
• Profound Medical names Richard Fabian as president